beta-endorphin (6-31)
beta-endorphin (6-31) Basic information
- Product Name:
- beta-endorphin (6-31)
- Synonyms:
-
- beta-endorphin (6-31)
- b-Lipotropin (64-89) (huMan)
- H-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu-OH
- 6-31-β-Endorphin (human)
- 6-31-β-Endorphin (sheep), 27-L-tyrosine-31-L-glutamic acid-
- 4 β-Endorphin (6-31) (human)
- 6-31-b-Endorphin (sheep),27-L-tyrosine-31-L-glutamic acid
- β-Lipotropin (64-89) (human)
- CAS:
- 77761-27-4
- MF:
- C131H218N34O40
- MW:
- 2909.36
- Mol File:
- 77761-27-4.mol
beta-endorphin (6-31) Chemical Properties
- Boiling point:
- 2671.5±65.0 °C(Predicted)
- Density
- 1.294±0.06 g/cm3(Predicted)
- Sequence
- Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu
beta-endorphin (6-31) Usage And Synthesis
Uses
β-Endorphin, an endogenous opioid neuropeptide, is an opioid receptor agonist. β-Endorphin binds preferentially to μ-opioid receptors and is produced in certain neurons of the central and peripheral nervous system and is one of three endorphins produced in humans. β-Endorphin can be used to reduce stress and maintain homeostasis in the body and is involved in neurological pain perception regulation[1].
in vivo
β-Endorphin (0.03 to 1.00?μg/kg, i.p., once) impairs retention of a one-trial inhibitory avoidance task in a dose-dependent manner in male Swiss mice immediately post-training. Also, it works in the process of memory consolidation[1].
| Animal Model: | Adult male Swiss mice (22-25 g)[1] |
| Dosage: | 0.03, 0.10, 0.30 or 1.00 μg/kg |
| Administration: | i.p., once |
| Result: | Significantly impaired retention at the doses of 0.03 and 0.10?μg/kg while not significantly affect retention as compared with the control group at the two higher doses of 0.30 and 1.00?μg/kg , but tended to increase retention as compared with the dose of 0.10?μg/kg. Increased latencies to step-through at the two higher doses of 0.30 and 1.00?μg/kg but no effect at lower doses. |
References
[1] Introini IB, et al. The impairment of retention induced by beta-endorphin in mice may be mediated by a reduction of central cholinergic activity. Behav Neural Biol. 1984 Jul;41(2):152-63. DOI:10.1016/s0163-1047(84)90527-2
beta-endorphin (6-31)Supplier
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 17705183659
- sales@njleonbiotech.com
- Tel
- 025-58361106-805 15951641583
- zhao.xu@njpeptide.com
- Tel
- +86-17380623303
- Caroline@youngshechem.com
beta-endorphin (6-31)(77761-27-4)Related Product Information
- β-Endorphin (1-27), camel, bovine, ovine
- BETA-ENDORPHIN (18-31) (HUMAN)
- BETA-ENDORPHIN (EQUINE)
- ALPHA-CGRP (19-37) (HUMAN)
- AC-DELTA-ENDORPHIN (HUMAN)
- Big Gastrin I Human
- CCK-33 (HUMAN)
- β-Endorphin (1-26), human
- BETA-ENDORPHIN (RAT)
- β-Endorphin (27-31) (human)
- H-Tyr-Lys-Lys-Gly-Glu-OH
- β-Endorphin (1-5), (16-31), human
- BETA-ENDORPHIN (CAMEL)
- GASTRIC INHIBITORY POLYPEPTIDE (6-30) AMIDE (HUMAN)
- H-SER-ALA-GLU-GLU-TYR-GLU-TYR-PRO-SER-OH
- ENTEROSTATIN, HUMAN
- H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Val-His-Lys-Lys-Gly-Gln-OH
- ACETYL-BETA-ENDORPHIN (HUMAN)